EP 4200285 A1 20230628 - NEW ISOBUTYRYAMIDE DERIVATIVES, COSMETIC AND/OR DERMATOLOGICAL PREPARATIONS CONTAINING SAID COMPOUNDS, AND THEIR USE FOR THE PROPHYLAXIS AND TREATMENT OF SENSIBLE, IN PARTICULAR INFLAMED SKIN OR INFLAMMATORY SKIN CONDITIONS
Title (en)
NEW ISOBUTYRYAMIDE DERIVATIVES, COSMETIC AND/OR DERMATOLOGICAL PREPARATIONS CONTAINING SAID COMPOUNDS, AND THEIR USE FOR THE PROPHYLAXIS AND TREATMENT OF SENSIBLE, IN PARTICULAR INFLAMED SKIN OR INFLAMMATORY SKIN CONDITIONS
Title (de)
NEUE ISOBUTYRAMIDDERIVATE, KOSMETISCHE UND/ODER DERMATOLOGISCHEN ZUBEREITUNGEN, SOLCHE VERBINDUNGEN ENTHALTEND, SOWIE DEREN VERWENDUNG ZUR PROPHYLAXE VOR UND BEHANDLUNG VON SENSIBLER, INSBESONDERE ENTZÜNDETER HAUT BZW. ENTZÜNDLICHEN HAUTZUSTÄNDEN
Title (fr)
NOUVEAUX DÉRIVÉS D'ISOBUTYRYLAMIDE, PRÉPARATIONS COSMÉTIQUES ET/OU DERMATOLOGIQUES CONTENANT CES COMPOSÉS ET LEUR UTILISATION POUR LA PROPHYLAXIE ET LE TRAITEMENT DE PEAUX SENSIBLES, EN PARTICULIER DE PEAUX ENFLAMMÉES OU D'AFFECTIONS CUTANÉS INFLAMMATOIRES
Publication
Application
Priority
- DE 102020210535 A 20200819
- EP 2021071523 W 20210802
Abstract (en)
[origin: WO2022037927A1] New isobutyramides.
IPC 8 full level
C07D 277/02 (2006.01); A61K 8/49 (2006.01); A61P 17/08 (2006.01); A61P 17/10 (2006.01); A61Q 19/00 (2006.01)
CPC (source: EP US)
A61K 8/49 (2013.01 - EP US); A61P 17/08 (2017.12 - EP); A61P 17/10 (2017.12 - EP); A61Q 19/008 (2013.01 - EP US); C07D 277/02 (2013.01 - EP); C07D 277/46 (2013.01 - US)
Citation (search report)
See references of WO 2022037927A1
Designated contracting state (EPC)
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated extension state (EPC)
BA ME
Designated validation state (EPC)
KH MA MD TN
DOCDB simple family (publication)
WO 2022037927 A1 20220224; BR 112023003093 A2 20230328; CN 116096346 A 20230509; DE 102020210535 A1 20220324; EP 4200285 A1 20230628; US 2023312495 A1 20231005
DOCDB simple family (application)
EP 2021071523 W 20210802; BR 112023003093 A 20210802; CN 202180055944 A 20210802; DE 102020210535 A 20200819; EP 21762623 A 20210802; US 202118041742 A 20210802